n=63, No significant changes in renal function were observedduring follow-up in most subjects, in spite of their age and the pres-ence of risk factors for CKD. This reinforces the safety of TDF/FTC for HIV PrEP in this age group. However, most of the patients had no previous risk factors and further studies with a longer period of monitoring are required.